U.S. Department of Health & Human Services

02/02/2023 | Press release | Distributed by Public on 02/02/2023 12:19

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.